CJC-1295 is a synthetic tetra-substituted peptide analog of growth hormone\u2011releasing hormone (GHRH) that has garnered interest in biochemical and endocrine research. Its primary molecular design involves four amino acid substitutions within the native GHRH(1\u201129) sequence together with a reactive linker group, which allows for site\u2011specific conjugation to serum albumin \u4f53\u5916<\/em>. This structural modification prolongs the experimental half\u2011life of the peptide under laboratory conditions, making it a valuable tool for long\u2011duration signaling studies. Researchers commonly employ CJC-1295 to investigate GHRH receptor binding kinetics, intracellular cAMP accumulation, and downstream pulsatile hormone release patterns in isolated pituitary cell models. All investigations are conducted solely in controlled laboratory environments; the product is not intended for any form of human or veterinary application.<\/p>\n The peptide\u2019s use is limited to basic science and early\u2011stage discovery programs where a stable GHRH receptor agonist is required. Typical experimental endpoints include receptor occupancy assays, transcriptional profiling of somatotrophs, and modulation of insulin\u2011like growth factor\u20111 secretion in established cell lines. By offering a consistent chemical identity and high batch\u2011to\u2011batch fidelity, CJC-1295 enables reproducible outcomes across multi\u2011institutional collaborations. As with all research\u2011grade peptides, the compound is distributed exclusively to qualified laboratories and must be handled in accordance with institutional safety guidelines.<\/p>\n Ensuring a reliable 99 percent purity level is fundamental for meaningful research data, and every batch of CJC-1295 from our facility undergoes rigorous analytical characterization before release. Our quality assurance program is built around orthogonal methods that confirm both the quantitative purity and the qualitative identity of the peptide. High\u2011performance liquid chromatography (HPLC) is the primary tool for purity assessment, while high\u2011resolution mass spectrometry verifies the expected molecular weight and absence of sequence deletions or side\u2011product modifications.<\/p>\n A Certificate of Analysis (CoA) accompanies each shipment, detailing the specific lot number, net peptide content, purity percentage determined by HPLC, mass spectrum, and residual solvent profile. This documentation allows researchers to correlate experimental results directly with the physicochemical properties of the peptide they received. In addition to end\u2011product testing, we employ a system of in\u2011process controls that monitor critical synthesis and purification steps. These measures collectively guarantee that every gram of CJC-1295 meets the 99 percent specification, thereby supporting the reproducibility that peer\u2011reviewed journals and institutional review boards expect from commercial peptide sources.<\/p>\n Manufacture of CJC-1295 begins with solid\u2011phase peptide synthesis (SPPS) using Fmoc\u2011protected amino acids. This stepwise assembly on a resin support enables precise control over the linear chain growth, minimizing racemization and deletion sequences. The reactive linker moiety is introduced during solid\u2011phase construction under optimized coupling conditions, ensuring consistent incorporation. After cleavage from the resin, the crude peptide is precipitated and lyophilized before entering the purification stage.<\/p>\n Reverse\u2011phase HPLC with a C18 stationary phase serves as the principal purification method. A water\u2011acetonitrile gradient containing a small percentage of trifluoroacetic acid resolves the target peptide from closely related deletion, truncation, and epimerization impurities. Fractions are collected and analyzed in real time by analytical HPLC, and only those meeting the \u226599 percent purity threshold are pooled. The final solution is then lyophilized under sterile conditions, yielding a white to off\u2011white powder that retains its stability for extended periods when stored correctly. Lyophilization removes water by sublimation, which prevents chemical degradation and microbial growth without the need for preservatives.<\/p>\n Verifying a 99 percent purity claim requires a multi\u2011technique approach that leaves no ambiguity about the peptide\u2019s identity or cleanliness. Our standard protocol begins with reversed\u2011phase analytical HPLC monitored by UV absorbance at 214 nm, a wavelength where the peptide bond exhibits strong absorption. The chromatogram is integrated to calculate the relative peak areas of the main product versus all detectable impurities. A single, symmetrical peak representing more than 99 percent of the total area serves as the primary acceptance criterion.<\/p>\n Electrospray ionization mass spectrometry (ESI\u2011MS) or matrix\u2011assisted laser desorption\/ionization time\u2011of\u2011flight (MALDI\u2011TOF) analysis confirms the molecular mass within \u00b10.5 Da of the theoretical monoisotopic value. This step detects any covalent modifications, such as oxidation of methionine residues or incomplete deprotection, that might escape HPLC resolution. Complementary analysis for residual organic solvents is performed by gas chromatography according to pharmacopeial guidelines, ensuring that levels of acetonitrile, trifluoroacetic acid, and other processing reagents fall below established safety thresholds for laboratory exposure. Only after these three independent tests are passed does a batch receive its lot number and CoA.<\/p>\n To reinforce confidence in our analytical results, we engage ISO\u2011accredited independent laboratories for periodic blinded verification. These third parties repeat the HPLC purity, mass spectrometry, and residual solvent analyses on randomly selected retention samples, and their reports are archived alongside our internal data. This external oversight provides an objective check on equipment calibration and operator proficiency. Furthermore, our synthesis and quality control procedures follow relevant Good Manufacturing Practice (GMP) principles adapted for research\u2011grade peptides, including raw material qualification, equipment cleaning validation, and controlled documentation of every production step.<\/p>\n All documentation, from the master batch record to the final CoA and third\u2011party summary, is available for regulatory review when research programs transition toward later\u2011stage development. This level of transparency supports the due diligence requirements of pharmaceutical distributors and institutional procurement departments. By maintaining a permanent audit trail, we help customers demonstrate the provenance and purity of the CJC-1295 used in their published studies, which is increasingly requested by journal editors and grant reviewers.<\/p>\n Maintaining the structural integrity of CJC-1295 during long\u2011term storage is essential for experimental consistency. Upon receipt, the lyophilized powder should be inspected for cake appearance and immediately transferred to a frost\u2011free freezer set at \u221220 \u00b0C or colder. Vials must be kept in a sealed container with desiccant to prevent moisture absorption, as even trace amounts of water can initiate deamidation or aggregation over time. Under these conditions, lyophilized CJC-1295 remains chemically stable for the duration stated on the CoA, typically 24 months from the date of manufacture.<\/p>\n For in vitro assays, the peptide is reconstituted in sterile, deionized water or an appropriate buffer (such as phosphate\u2011buffered saline, pH 7.4) at a concentration suitable for the experimental design, typically 1\u20115 mg\/mL. Gentle swirling\u2014never vortexing\u2014dissolves the material without foaming or shear\u2011induced aggregation. The resulting stock solution should be aliquoted into single\u2011use portions and stored at \u221220 \u00b0C or \u221280 \u00b0C. Repeated freeze\u2011thaw cycles are detrimental, as they expose the peptide to fluctuating solute concentrations and ice\u2011crystal interfaces that accelerate degradation. Researchers are advised to thaw each aliquot once, immediately before use, and to discard any unused thawed solution.<\/p>\n As a direct manufacturer with dedicated peptide synthesis laboratories, we offer CJC-1295 in quantities ranging from milligrams to multi\u2011gram bulk orders, all produced to the same 99 percent purity standard. This vertical integration eliminates intermediaries, shortens lead times, and permits real\u2011time customization of packaging and labeling to suit institutional requirements. We employ a just\u2011in\u2011time production model for high\u2011demand items, which reduces the need for prolonged storage at our facility and ensures that customers receive freshly synthesized material with maximum remaining shelf life.<\/p>\n Price competitiveness is achieved without sacrificing quality. Our process development team continually refines coupling cycles, cleavage conditions, and HPLC gradients to maximize yield per synthesis run, and these efficiencies translate into lower cost per gram for the end user. Large\u2011scale orders benefit from additional economy while still receiving the full suite of analytical documentation. Every shipment, irrespective of size, is dispatched in temperature\u2011controlled packaging with data\u2011logging devices that record the cold chain from our warehouse to the receiving dock. This commitment to cold\u2011chain integrity is particularly critical for lyophilized peptides, as prolonged ambient exposure during transit can shorten usable life. For international orders, we provide the necessary customs documentation to facilitate smooth clearance, and dedicated customer support representatives track each parcel until delivery confirmation.<\/p>\n What is the typical lead time for orders?<\/strong> How is purity guaranteed for long\u2011term research projects?<\/strong> What documentation accompanies each shipment?<\/strong> All products listed on this website and sold to customers are intended solely for laboratory research use. They are not designed, labeled, or authorized for use as drugs, food additives, cosmetics, or for any direct human or veterinary application. The purchaser assumes all responsibility for compliance with applicable regulations and for determining the suitability of the product for their specific experimental purposes.<\/em><\/p>\n \u4ec5\u9650\u7814\u7a76\u7528\u9014\u3002\u4e0d\u5f97\u7528\u4e8e\u4eba\u7c7b\u6216\u517d\u533b\u7528\u9014\u3002.<\/em><\/p>","protected":false},"excerpt":{"rendered":" Introduction to CJC-1295 for Research Applications CJC-1295 is a synthetic tetra-substituted peptide analog of growth hormone\u2011releasing hormone (GHRH) that has garnered interest in biochemical and endocrine research. Its primary molecular design involves four amino acid substitutions within the native GHRH(1\u201129) sequence together with a reactive linker group, which allows for site\u2011specific conjugation to serum albumin […]<\/p>\n","protected":false},"author":1,"featured_media":1803,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"news_category":[],"class_list":["post-1802","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"yoast_head":"\nQuality Assurance in CJC-1295 Supply<\/h2>\n
Synthesis and Purification Methods<\/h3>\n
Purity Verification Protocols<\/h2>\n
Third-Party Testing and Compliance<\/h3>\n
Proper Storage and Handling for Research Use<\/h2>\n
Why Choose Our CJC-1295 for Your Research<\/h2>\n
Frequently Asked Questions about CJC-1295 Supply<\/h2>\n
\nStandard catalog quantities (5 mg to 100 mg) usually ship within 3\u20115 business days after order confirmation. Custom bulk orders may require 2\u20114 weeks for synthesis, purification, and quality release. The exact timeline is provided at quotation stage, and we offer expedited synthesis slots for repeat customers with pre\u2011approved specifications.<\/p>\n
\nWe maintain a retention sample of every batch and perform annual stability\u2011indicating HPLC and mass spectrometry tests on these samples. If a project spans multiple years, we can reserve a dedicated lot from a single synthesis run, providing an extensive stability dataset that covers the entire project lifetime. Re\u2011analysis certificates are issued upon request, allowing investigators to confirm that peptide integrity has remained unchanged while in their own laboratory storage.<\/p>\n
\nInside every package, researchers will find a hard copy of the Certificate of Analysis, which includes HPLC purity, net peptide weight, mass spectrum, and residual solvent data. A materials safety data sheet (MSDS) and a product information sheet with handling instructions are also included. Electronic copies are archived in our customer portal for convenient retrieval during manuscript preparation or grant reporting.<\/p>\n